Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Crescita Therapeutics Inc
T.CTX
Alternate Symbol(s):
CRRTF
Healthcare
Drug Manufacturers - Specialty & Generic
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers...
and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The company’s prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products ...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (TSX:CTX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(1208)
•••
lscfa
X
Post by
lscfa
on Mar 16, 2026 11:45am
Buy out
https://stockhouse.com/news/press-releases/2026/03/16/crescita-announces-definitive-agreement-to-be-acquired-by-clinactiv-holdings-in
(1721)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Mar 16, 2026 10:20am
Mathieu Martin comment on offer
Mathieu Martin, CFAMathieu Martin, CFA • 3rd+3rd+ MicroCap Expert | Portfolio Manager Newsletter Writer I help you invest in small public companiesMicroCap Expert | Portfolio Manager
...more
(3)
•••
stamps56
X
Post by
stamps56
on Mar 11, 2026 10:45am
Profit
Earnings any day now ++
(3)
•••
stamps56
X
Post by
stamps56
on Mar 05, 2026 11:01am
Growth
It appears they are finally getting some growth in this company
(1721)
•••
Possibleidiot01
X
Comment by
Possibleidiot01
on Nov 25, 2025 6:05pm
RE:52 week low
Anda again
(1208)
•••
lscfa
X
Post by
lscfa
on Nov 06, 2025 8:07am
Q3 on sedar
Qtr ending Skincare Licensing Manufacturing Total rev ebitda
...more
(1721)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Nov 03, 2025 5:58pm
52 week low
44 cents
(1208)
•••
lscfa
X
Comment by
lscfa
on Aug 06, 2025 10:25am
RE:Q2
Qtr ending Skincare Licensing Manufacturing Total rev ebitda
...more
(1721)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Aug 06, 2025 9:09am
Q2
I appreciate managment making this one point clear. “We are pleased with the positive results for the quarter, which showed significant year-over-year improvement and strengthened our position as we
...more
(1208)
•••
lscfa
X
Post by
lscfa
on Mar 18, 2025 1:06pm
Q4 results
Qtr ending Skincare Licensing Manufacturing Total rev ebitda
...more
(10)
•••
Rahil1234
X
Post by
Rahil1234
on Feb 11, 2025 8:10pm
Crescita's Comeback: Strategic Growth and Key Acquisitions
https://substack.com/home/post/p-156966361
(1721)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Oct 23, 2024 3:17pm
Mathieu Martin - Stocks and Stones
#5 - Crescita Therapeutics (TSX: CTX) Those who’ve been following Crescita for a significant amount of time know that the stock has been a value trap. Although the business has
...more
(1721)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Sep 05, 2024 5:22pm
addition to latest Atrium takeover report
https://mcusercontent.com/4bc421505c66d079778a0d0be/files/c84f1943-b069-7c62-f72d-87f54a469d3b/20240905_Atrium_Takeouts_Part_3.02.pdf Small-Cap Takeouts Thematic Research 4September 5, 2024 Crescita
...more
(1721)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Aug 09, 2024 5:43pm
Mathieu Martin - Stocks and Stones
Crescita Therapeutics (TSX: CTX) is firing on all cylinders. In the span of a week, CTX announced a distribution agreement for a new medical aesthetic product, a new long-term manufacturing deal for
...more
(1208)
•••
lscfa
X
Post by
lscfa
on Jul 22, 2024 9:50am
$10M 4 yr contract
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years LAVAL, Quebec--(BUSINESS WIRE)--July 22, 2024--Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or
...more
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Western Star Resources Expands Its Past Producing Rowland Tungsten Property by 170%
Airborne geophysical survey commences at Haldane Silver Project at Keno Hill Silver District, Yukon
Podcasts